Monitoring Cancer Treatment Response With PET, Part 1: The Future of Nuclear Medicine Barry L Shulkin, MD, MBA
•
Monitoring Cancer Treatment Response With PET, Part 2: The Future of Nuclear Medicine Barry L Shulkin, MD, MBA
•
Novel Applications for PET: Emergent Agents, Alzheimer's Disease, and Addiction Imaging Barry L Shulkin, MD, MBA
More...
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the Society of Nuclear Medicine. These materials and the related activity are not sanctioned by the Society of Nuclear Medicine or the commercial supporter of the conference, and do not constitute an official part of that conference.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
